, Aspect clinique des états dépressifs. L'Encéphale, p.33, 2007.
, Les dérèglements de l'humeur, 1946.
A different depression: clinical distinctions between bipolar and unipolar depression, Journal of affective disorders, vol.84, issue.2-3, pp.117-125, 2005. ,
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review, The Lancet, vol.361, issue.9358, pp.653-661, 2003. ,
, Diagnostic and statistical manual of mental health disorders, DSM 5, 2013.
, International Statistical Classification of Diseases and Related Health Problems: tenth revision-Version for, World Health Organization, 2007.
A rating scale for depression, Journal of neurology, vol.23, issue.1, p.56, 1960. ,
A new depression scale designed to be sensitive to change, The British journal of psychiatry, vol.134, issue.4, pp.382-389, 1979. ,
, Prévalence et comorbidité des troubles psychiatriques dans la population générale française: résultats de l'étude épidémiologique ESEMeD/MHEDEA 2000/(ESEMeD). L'encéphale, vol.31, pp.182-194, 2005.
, The global burden of disease: 2004 update, World Health Organization, 2008.
The cost of mental disorders in France, European Neuropsychopharmacology, vol.23, issue.8, pp.879-886, 2013. ,
The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys, International journal of methods in psychiatric research, vol.12, issue.1, pp.3-21, 2003. ,
, INPES, 2005.
Gender differences in mental disorders and suicidality in Europe: results from a large cross-sectional population-based study, Journal of affective disorders, vol.173, pp.245-254, 2015. ,
Risks of all-cause and suicide mortality in mental disorders: a meta-review, World Psychiatry, vol.13, issue.2, pp.153-160, 2014. ,
Imaging the pathophysiology of major depressive disorder-from localist models to circuit-based analysis, Biology of mood & anxiety disorders, vol.4, issue.1, p.5, 2014. ,
A pathophysiological paradigm for the therapy of psychiatric disease, Nature Reviews Drug Discovery, vol.4, issue.6, p.467, 2005. ,
Facteurs non spécifiques de variations de paramètres biologiques étudiés en psychiatrie biologique. Discussion, Annales médicopsychologiques, vol.150, pp.181-186, 1992. ,
Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders, Current opinion in neurobiology, vol.11, issue.2, pp.240-249, 2001. ,
The catecholamine hypothesis of affective disorders: a review of supporting evidence, American journal of Psychiatry, vol.122, issue.5, pp.509-522, 1965. ,
Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder, Journal of affective disorders, vol.140, issue.2, pp.142-148, 2012. ,
Cortico-limbic network abnormalities in individuals with current and past major depressive disorder, Journal of affective disorders, vol.173, pp.45-52, 2015. ,
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain structure and function, vol.213, pp.93-118, 2008. ,
Major depressive disorder, New England Journal of Medicine, vol.358, issue.1, pp.55-68, 2008. ,
The molecular neurobiology of depression, Nature, vol.455, issue.7215, p.894, 2008. ,
The American psychiatric publishing textbook of psychopharmacology, 2009. ,
The importance of norepinephrine in depression, Neuropsychiatric disease and treatment, vol.7, p.9, 2011. ,
The role of norepinephrine and its ?-adrenergic receptors in the pathophysiology and treatment of major depressive disorder and schizophrenia: a systematic review, Frontiers in psychiatry, vol.8, p.42, 2017. ,
The role of dopamine in the pathophysiology of depression, Archives of general psychiatry, vol.64, issue.3, pp.327-337, 2007. ,
Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression, Nature Reviews Neuroscience, vol.17, issue.8, p.524, 2016. ,
Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine, Biological psychiatry, vol.81, issue.10, pp.886-897, 2017. ,
Book review: GABA and glutamate in the human brain, The Neuroscientist, vol.8, issue.6, pp.562-573, 2002. ,
Psychopathology of depression, Drugs of Today, vol.43, issue.10, pp.705-716, 2007. ,
Emerging role of glutamate in the pathophysiology of major depressive disorder, Brain research reviews, vol.61, issue.2, pp.105-123, 2009. ,
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders, Neuropharmacology, vol.62, issue.1, pp.63-77, 2012. ,
The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders, The Neuroscientist, vol.15, issue.5, pp.525-539, 2009. ,
Overview of glutamatergic neurotransmission in the nervous system, Pharmacology Biochemistry and Behavior, vol.100, issue.4, pp.656-664, 2012. ,
Introduction to the glutamate-glutamine cycle, The Glutamate/GABA-Glutamine Cycle, pp.1-7, 2016. ,
From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders, Biological psychiatry, vol.73, issue.12, pp.1172-1179, 2013. ,
GABA receptors in brain development, function, and injury. Metabolic brain disease, vol.30, pp.367-379, 2015. ,
Malfunction in GABA and glutamate as pathways to depression: a review of the evidence, Clinical Medicine. Therapeutics, vol.1, p.3481, 2009. ,
Depression viewed as a GABA/glutamate imbalance in the central nervous system, Clinical, Research and Treatment Approaches to Affective Disorders, 2012. ,
Pathophysiology of depression: do we have any solid evidence of interest to clinicians, World Psychiatry, vol.9, issue.3, pp.155-161, 2010. ,
Increased serum glutamate in depressed patients, Archiv für Psychiatrie und Nervenkrankheiten, vol.232, issue.4, pp.299-304, 1982. ,
DOI : 10.1007/bf00345492
Plasma and platelet excitatory amino acids in psychiatric disorders, The American journal of psychiatry, vol.150, issue.11, p.1731, 1993. ,
Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment, Neuropsychobiology, vol.37, issue.3, pp.124-129, 1998. ,
DOI : 10.1159/000026491
Correlation between plasma levels of glutamate, alanine and serine with severity of depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.30, issue.6, pp.1155-1158, 2006. ,
Increased cerebrospinal fluid glutamine levels in depressed patients, Biological psychiatry, vol.47, issue.7, pp.586-593, 2000. ,
DOI : 10.1016/s0006-3223(99)00284-x
Low cerebrospinal fluid glutamate and glycine in refractory affective disorder, Biological psychiatry, issue.2, pp.162-166, 2007. ,
DOI : 10.1016/j.biopsych.2006.01.024
NMDA glutamatergic receptors, labelled with [3H] MK-801, in brain samples from drug-free depressed suicides, Brain research, vol.616, issue.1-2, pp.138-143, 1993. ,
DOI : 10.1016/0006-8993(93)90202-x
GABA levels in CSF of patients with psychiatric disorders. The American journal of psychiatry, 1980. ,
Low plasma ?aminobutyric acid levels in male patients with depression, Biological psychiatry, vol.32, issue.4, pp.354-363, 1992. ,
DOI : 10.1016/0006-3223(92)90039-3
Reduced expression of GABA transporter GAT3 in helpless rats, an animal model of depression, Neurochemical research, vol.34, issue.9, pp.1584-1593, 2009. ,
Distinct changes in neuronal and astrocytic amino acid neurotransmitter metabolism in mice with reduced numbers of synaptic vesicles, Journal of neurochemistry, vol.105, issue.6, pp.2524-2534, 2008. ,
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study, Biological psychiatry, vol.47, issue.4, pp.305-313, 2000. ,
Different relationships among cortical amino acids in unipolar and bipolar depression, Proceedings of the International Society of Magnetic Resonance, vol.9, pp.557-565, 2001. ,
Reduced prefrontal glutamate/glutamine and ?-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy, Archives of general psychiatry, vol.64, issue.2, pp.193-200, 2007. ,
DOI : 10.1001/archpsyc.64.2.193
URL : http://archpsyc.jamanetwork.com/data/journals/psych/11838/yoa60057_193_200.pdf
Subtype-specific alterations of ?-aminobutyric acid and glutamatein patients with major depression, Archives of general psychiatry, issue.7, pp.705-713, 2004. ,
Reduction in occipital cortex ?-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects, Biological psychiatry, issue.6, pp.806-812, 2007. ,
DOI : 10.1016/j.biopsych.2006.08.048
Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: meta-analysis of absolute prefrontal neuro-metabolic concentrations, European Neuropsychopharmacology, vol.25, issue.8, pp.1109-1117, 2015. ,
Reduced cortical ?-aminobutyric acid levels in depressed patients 157 determined by proton magnetic resonance spectroscopy, Archives of general psychiatry, vol.56, issue.11, pp.1043-1047, 1999. ,
Impairment of GABAergic transmission in depression: new insights from neuroimaging studies, Critical Reviews? in Neurobiology, vol.14, issue.1, 2000. ,
Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors, American Journal of Psychiatry, vol.159, issue.4, pp.663-665, 2002. ,
Increased cortical GABA concentrations in depressed patients receiving ECT, American Journal of Psychiatry, vol.160, issue.3, pp.577-579, 2003. ,
Cortical ?-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy, Biological psychiatry, vol.59, issue.3, pp.284-286, 2006. ,
Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients, International Journal of Neuropsychopharmacology, vol.11, issue.2, pp.255-260, 2008. ,
Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy, Biological psychiatry, vol.58, issue.12, pp.969-973, 2005. ,
Beyond monoamines: glutamatergic function in mood disorders, CNS spectrums, vol.10, issue.10, pp.808-819, 2005. ,
Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims, Brain research, vol.675, issue.12, pp.157-164, 1995. ,
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15653-15658, 2005. ,
Expression of GABA A ?2-, ?1-and ?-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder, Translational psychiatry, vol.3, issue.9, p.303, 2013. ,
Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil, Journal of affective disorders, vol.113, issue.1-2, pp.45-55, 2009. ,
A meta-analysis of memantine for depression, Journal of Alzheimer's Disease, vol.57, issue.1, pp.113-121, 2017. ,
Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression, American Journal of Psychiatry, vol.172, issue.10, pp.950-966, 2015. ,
The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials, Journal of affective disorders, vol.136, issue.1-2, pp.31-39, 2012. ,
Magnesium in depression, Pharmacological Reports, vol.65, issue.3, pp.547-554, 2013. ,
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder, Journal of clinical psychopharmacology, vol.28, issue.6, pp.631-637, 2008. ,
Lamotrigine in psychiatric disorders, The Journal of clinical psychiatry, vol.74, issue.7, pp.675-684, 2013. ,
Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry, vol.125, pp.265-269, 1979. ,
Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six doubleblind studies versus tricyclics, Neuropsychobiology, vol.20, issue.3, pp.126-131, 1988. ,
Behavioural studies of the role of GABA in anxiolytic drug action, Neuropharmacology, 1984. ,
Chronic antidepressants and GABA-B? receptors: a GABA hypothesis of antidepressant drug action, Life sciences, vol.35, issue.21, pp.2149-2154, 1984. ,
Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis, 2018. ,
The potential efficacy of GABAB antagonists in depression. Current opinion in pharmacology, 2017. ,
GABA and glutamate systems as therapeutic targets in depression and mood disorders, Expert opinion on therapeutic targets, vol.9, issue.1, pp.153-168, 2005. ,
Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review, Psychological bulletin, vol.139, issue.1, p.81, 2013. ,
Examining emotion regulation in depression: a review and future directions, Behaviour Research and Therapy, vol.86, pp.35-49, 2016. ,
Facial emotion perception in depression and bipolar disorder: a quantitative review, Psychiatry research, vol.188, issue.3, pp.303-309, 2011. ,
The role glutamate excitotoxicity and neuroinflammation in depression and suicidal behavior: focus on microglia cells, Neuroimmunol Neuroinflamm, vol.2, issue.2, pp.127-157, 2015. ,
NMDA receptor-dependent regulation of axonal and dendritic branching, Journal of Neuroscience, vol.25, issue.9, pp.2304-2311, 2005. ,
Mechanisms of stress in the brain, Nature neuroscience, vol.18, issue.10, p.1353, 2015. ,
Local ?-aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin-releasing factor neuron activity in the paraventricular nucleus of the hypothalamus, European Journal of Neuroscience, vol.19, issue.3, pp.777-782, 2004. ,
GABAergic mechanisms constraining the activity of the hypothalamo-pituitary-adrenocortical axis, Annals of the New York Academy of Sciences, vol.1018, issue.1, pp.466-476, 2004. ,
Neuroendocrine Abnormalities in Major Depression: An Insight Into Glucocorticoids, Cytokines, and the Kynurenine Pathway, Inflammation and Immunity in Depression, pp.45-60, 2018. ,
A hypothesized role for dendritic remodeling in the etiology of mood and anxiety disorders, The Journal of neuropsychiatry and clinical neurosciences, vol.22, issue.3, pp.256-264, 2010. ,
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression, International Journal of Neuropsychopharmacology, vol.11, issue.8, pp.1169-1180, 2008. ,
Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation, Current opinion in neurobiology, vol.13, issue.3, pp.366-371, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00079635
Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders, Seminars in cell & developmental biology, vol.53, pp.136-143, 2016. ,
Serotonin as a modulator of glutamate-and GABA-mediated neurotransmission: implications in physiological functions and in pathology, Current neuropharmacology, vol.4, issue.2, pp.101-114, 2006. ,
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression, Molecular psychiatry, vol.12, issue.11, p.988, 2007. ,
Evidence for a GABAergic inhibitory influence on serotonergic neurons originating from the dorsal raphe, Brain Research, vol.279, issue.1-2, pp.325-329, 1983. ,
Altered brain activity in unipolar depression revisited: meta-analyses of neuroimaging studies, JAMA psychiatry, vol.74, issue.1, pp.47-55, 2017. ,
The molecular neurobiology of depression, Nature, vol.455, issue.7215, p.894, 2008. ,
Neurobiological mechanisms in major depressive disorder, Canadian Medical Association Journal, vol.180, issue.3, pp.305-313, 2009. ,
Pharmaco-transcranial magnetic stimulation studies of motor excitability, Handbook of clinical neurology, vol.116, pp.387-397, 2013. ,
DOI : 10.1016/b978-0-444-53497-2.00032-2
Stress, depression, and neuroplasticity: a convergence of mechanisms, Neuropsychopharmacology, vol.33, issue.1, p.88, 2008. ,
Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Archives of general psychiatry, vol.48, pp.851-855, 1991. ,
Natural history of Diagnostic Interview Schedule/DSM-IV major depression: The Baltimore epidemiologic catchment area follow-up, Archives of general psychiatry, vol.54, issue.11, pp.993-999, 1997. ,
DOI : 10.1001/archpsyc.1997.01830230023003
Predictors of response to antidepressants: General principles and clinical implications. Psychiatric Clinics of North America, 2003. ,
DOI : 10.1016/s0193-953x(02)00105-3
Symptômes résiduels après traitement antidépresseur d'un épisode dépressif majeur: observatoire réalisé en pratique ambulatoire de ville, L'Encéphale, vol.29, issue.5, pp.438-444, 2003. ,
Risk for recurrence in depression, Clinical psychology review, vol.27, issue.8, pp.959-985, 2007. ,
ECT in treatment-resistant depression, American Journal of Psychiatry, vol.169, issue.12, pp.1238-1244, 2012. ,
DOI : 10.1176/appi.ajp.2012.12050648
Risk factors for suicide in individuals with depression: a systematic review, Journal of affective disorders, vol.147, issue.1-3, pp.17-28, 2013. ,
DOI : 10.1016/j.jad.2013.01.004
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications, Molecular psychiatry, vol.18, issue.5, p.595, 2013. ,
Evidence for clinical progression of unipolar and bipolar disorders, Acta Psychiatrica Scandinavica, vol.135, issue.1, pp.51-64, 2017. ,
Mechanisms of illness progression in the recurrent affective disorders, Neurotoxicity research, vol.18, issue.3-4, pp.256-271, 2010. ,
Severity of depressive episodes during the course of depressive disorder, The British Journal of Psychiatry, vol.192, issue.4, pp.290-293, 2008. ,
Course and cognitive outcome in major affective disorder, Danish medical journal, vol.62, issue.11, pp.5160-5160, 2015. ,
The Course of Major Depressive Disorder from Childhood to Young Adulthood: Recovery and Recurrence in a Longitudinal Observational Study, Journal of Affective Disorders, vol.203, pp.374-381, 2016. ,
Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders, Neuroprogression in Psychiatric Disorders, vol.31, pp.37-55, 2017. ,
Increased limbic system symptomatology and sensitizability of young adults with chemical and noise sensitivities, Environmental research, vol.70, issue.2, pp.84-97, 1995. ,
T0 LOW-LEVEL CHEMICALS: A NEURAL SENSITIZATION MODEL, Toxicology and Industrial Health, vol.2, issue.425, pp.277-312, 1994. ,
Manic depressive insanity and paranoia, The Journal of Nervous and Mental Disease, vol.53, issue.4, p.350, 1921. ,
Life stress, the" kindling" hypothesis, and the recurrence of depression: considerations from a life stress perspective, Psychological review, vol.112, issue.2, p.417, 2005. ,
A critical overview of the clinical evidence supporting the concept of neuroprogression in bipolar disorder, Psychiatry Res, vol.235, pp.1-6, 2016. ,
A new paradigm for the prediction of antidepressant treatment response, Dialogues in clinical neuroscience, vol.11, issue.4, p.435, 2009. ,
Biomarkers Definitions Working Group. Biomarkers and Surrogate Endpoints, Clinical Pharmacology & Therapeutics, vol.69, pp.89-95, 2001. ,
Remission versus response: the new gold standard of antidepressant care, Journal of Clinical Psychiatry, pp.53-59, 2004. ,
Objective: remission of depression in primary care: the OREON Study, European Neuropsychopharmacology, vol.19, issue.3, pp.169-176, 2009. ,
Sequenced treatment alternatives to relieve depression (STAR* D): rationale and design, Controlled clinical trials, vol.25, issue.1, pp.119-142, 2004. ,
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report, American Journal of Psychiatry, vol.163, issue.11, pp.1905-1917, 2006. ,
Episode dépressif caractérisé de l'adulte: prise en charge en soins de premier recours, 2017. ,
Guideline watch: practice guideline for the treatment of patients with major depressive disorder, Focus, vol.3, issue.1, pp.34-42, 2005. ,
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice, American journal of Psychiatry, vol.163, issue.1, pp.28-40, 2006. ,
The sequenced treatment alternatives to relieve depression (STAR* D) trial: a review, The Canadian Journal of Psychiatry, vol.55, issue.3, pp.126-135, 2010. ,
Continuity of antidepressant treatment for adults with depression in the United States, American Journal of psychiatry, vol.163, issue.1, pp.101-108, 2006. ,
Differences in mechanism of action between current and future antidepressants, The Journal of clinical psychiatry, vol.64, pp.13-17, 2003. ,
Medication augmentation after the failure of SSRIs for depression, New England Journal of Medicine, vol.354, issue.12, pp.1243-1252, 2006. ,
Biomarkers for Rapid Identification of Treatment Effectiveness (BRITE): testing symptoms and biomarkers as predictors of response and remission in MDD, Presented as poster at the Annual Meeting of the American Psychiatric Association, pp.3-8, 2008. ,
Biomarkers to predict antidepressant response, Current psychiatry reports, vol.12, issue.6, pp.553-562, 2010. ,
Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients, The Journal of clinical psychiatry, 2009. ,
Non-invasive magnetic stimulation of human motor cortex, Lancet, vol.843, pp.1106-1107, 1985. ,
Corticocortical inhibition in human motor cortex, The Journal of physiology, vol.471, issue.1, pp.501-519, 1993. ,
A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders, Clinical Neurophysiology, vol.124, issue.7, pp.1309-1320, 2013. ,
Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Annals of physical and rehabilitation medicine, vol.58, pp.208-213, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01202513
The contribution of transcranial magnetic stimulation in the functional evaluation of microcircuits in human motor cortex, Frontiers in neural circuits, vol.7, p.18, 2013. ,
A method of monitoring function in corticospinal pathways during scoliosis surgery with a note on motor conduction velocities, Neurosurgery & Psychiatry, vol.49, issue.3, pp.251-257, 1986. ,
Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans, Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control, vol.109, issue.5, pp.397-401, 1998. ,
Comparison of descending volleys evoked by monophasic and biphasic magnetic stimulation of the motor cortex in conscious humans, Experimental brain research, vol.141, issue.1, pp.121-127, 2001. ,
State of the art: physiology of transcranial motor cortex stimulation, Brain Stimulation, vol.1, issue.4, pp.345-362, 2008. ,
Determining which mechanisms lead to activation in the motor cortex: a modeling study of transcranial magnetic stimulation using realistic stimulus waveforms and sulcal geometry, Clinical neurophysiology, vol.122, issue.4, pp.748-758, 2011. ,
Half sine, monophasic and biphasic transcranial magnetic stimulation of the human motor cortex, Clinical Neurophysiology, vol.117, issue.4, pp.838-844, 2006. ,
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research, Clinical neurophysiology, vol.120, issue.12, pp.2008-2039, 2009. ,
A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression, International Journal of Neuropsychopharmacology, vol.11, issue.1, pp.131-147, 2008. ,
Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex, The Journal of physiology, vol.589, issue.23, pp.5845-5855, 2011. ,
Magnetic stimulation: motor evoked potentials, ElectroencephalogrClinNeurophysiolSuppl, vol.52, pp.97-103, 1999. ,
Variability of motor potentials evoked by transcranial magnetic stimulation, Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section, vol.89, issue.6, pp.415-423, 1993. ,
Measurement of central motor conduction in multiple sclerosis by magnetic brain stimulation, The Lancet, vol.328, issue.8503, pp.355-358, 1986. ,
Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an IFCN Committee, Clinical Neurophysiology, vol.126, issue.6, pp.1071-1107, 2015. ,
Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans, The Journal of physiology, vol.498, issue.3, pp.817-823, 1997. ,
Effect of exercise on motor evoked potentials elicited by transcranial magnetic stimulation in psychiatric patients, Journal of clinical neurophysiology, vol.19, issue.3, pp.240-244, 2002. ,
Cortical excitability of psychiatric disorders: reduced post-exercise facilitation in depression compared to schizophrenia and controls, Australian & New Zealand Journal of Psychiatry, vol.36, issue.5, pp.669-673, 2002. ,
Reduced cortical excitability in depression. Impaired post-exercise motor facilitation with transcranial magnetic stimulation, The British Journal of Psychiatry, vol.174, issue.5, pp.449-454, 1999. ,
Evidence for impaired cortical inhibition in patients with unipolar major depression, Biological psychiatry, vol.59, issue.5, pp.395-400, 2006. ,
Evidence of cortical inhibitory deficits in major depressive disorder, Biological psychiatry, vol.67, issue.5, pp.458-464, 2010. ,
Electrophysiological responses to transcranial magnetic stimulation in depression and schizophrenia, Biological psychiatry, vol.40, issue.2, pp.148-150, 1996. ,
Motor-evoked potential amplitudes elicited by transcranial magnetic stimulation do not differentiate between patients and normal controls, International Journal of Neuropsychopharmacology, vol.6, issue.4, pp.371-378, 2003. ,
Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation, Journal of psychiatric research, vol.42, issue.5, pp.389-398, 2008. ,
Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation, The British Journal of Psychiatry, vol.177, issue.2, pp.169-173, 2000. ,
A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability-A pharmacogenetic transcranial magnetic stimulation study, Epilepsia, vol.55, issue.2, pp.362-369, 2014. ,
Effects of aging on motor cortex excitability, Neuroscience research, vol.55, issue.1, pp.74-77, 2006. ,
Age and sex differences in human motor cortex input-output characteristics, The Journal of physiology, vol.546, issue.2, pp.605-613, 2003. ,
Cortical hypoexcitability in chronic smokers? A transcranial magnetic stimulation study, Neuropsychopharmacology, vol.33, issue.10, p.2517, 2008. ,
Does caffeine modify corticomotor excitability, Neurophysiologie Clinique, vol.36, issue.4, pp.219-226, 2006. ,
Inhibition of human motor cortex by ethanol A transcranial magnetic stimulation study, Brain, vol.118, issue.6, pp.1437-1446, 1995. ,
Menstrual cycle effects on cortical excitability, Neurology, vol.53, issue.9, pp.2069-2069, 1999. ,
Changes of transcranially evoked motor responses in man by midazolam, a short acting benzodiazepine, Neuroscience letters, vol.101, issue.3, pp.321-324, 1989. ,
Lorazepam-induced effects on silent period and corticomotor excitability, Experimental brain research, vol.173, issue.4, pp.603-611, 2006. ,
Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex, European Journal of Neuroscience, vol.32, issue.7, pp.1215-1222, 2010. ,
Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans, Experimental Brain Research, vol.109, issue.3, pp.467-472, 1996. ,
Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline, Neuroscience letters, vol.319, issue.2, pp.116-120, 2002. ,
Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects, Neuroimage, vol.27, issue.2, pp.314-322, 2005. ,
Methylphenidate facilitates and disinhibits the motor cortex in intact humans, Neuroreport, vol.14, issue.5, pp.773-776, 2003. ,
Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine, Neuroscience letters, vol.330, issue.3, pp.231-234, 2002. ,
Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study, Annals of neurology, vol.40, issue.3, pp.367-378, 1996. ,
Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men, Neuropsychopharmacology, vol.29, issue.7, p.1395, 2004. ,
Ketamine increases human motor cortex excitability to transcranial magnetic stimulation, The Journal of physiology, vol.547, issue.2, pp.485-496, 2003. ,
Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity, The Journal of physiology, vol.545, issue.1, pp.153-167, 2002. ,
Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex, Clinical Neurophysiology, vol.111, issue.5, pp.794-799, 2000. ,
Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans, The Journal of physiology, vol.564, issue.2, pp.661-668, 2005. ,
Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition, The Journal of physiology, vol.569, issue.1, pp.315-323, 2005. ,
Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study, Journal of the neurological sciences, vol.221, issue.1, pp.41-46, 2004. ,
Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex and cortical excitability in patients with major depressive disorder, Experimental neurology, vol.196, issue.2, pp.332-338, 2005. ,
Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks (KETADEP), 2013. ,
Evidence for pretreatment LICI deficits among depressed children and adolescents with nonresponse to fluoxetine, Brain stimulation, vol.7, issue.2, pp.243-251, 2014. ,
The Hamilton Depression Rating Scale: has the gold standard become a lead weight, American Journal of Psychiatry, vol.161, issue.12, pp.2163-2177, 2004. ,
Predictive validity of a medication adherence measure in an outpatient setting, The Journal of Clinical Hypertension, vol.10, issue.5, pp.348-354, 2008. ,
Internal consistency, retest reliability, and their implications for personality scale validity. Personality and social psychology review, vol.15, pp.28-50, 2011. ,
Individual differences in GABA content are reliable but are not uniform across the human cortex, NeuroImage, vol.139, pp.1-7, 2016. ,
Cerebral lateralization, Current Opinion in Neurobiology, vol.3, issue.2, pp.183-186, 1993. ,
The assessment and analysis of handedness: the Edinburgh inventory, Neuropsychologia, vol.9, issue.1, pp.97-113, 1971. ,
A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee, Clinical Neurophysiology, vol.123, issue.5, pp.858-882, 2012. ,
Reliability of motor cortex transcranial magnetic stimulation in four muscle representations, Clinical neurophysiology, vol.117, issue.5, pp.1037-1046, 2006. ,
Mapping the hand, foot and face representations in the primary motor cortex-retest reliability of neuronavigated TMS versus functional MRI, Neuroimage, vol.66, pp.531-542, 2013. ,
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression, Neuroreport: An International Journal for, 1995. ,
Transcranial magnetic stimulation and the challenge of coil placement: a comparison of conventional and stereotaxic neuronavigational strategies, Human brain mapping, vol.29, issue.1, pp.82-96, 2008. ,
Cortextool: a signal processing toolbox for cortical excitability by transcranial magnetic stimulation, 2013. ,
Brain state dependency of corticospinal excitability, Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation, vol.10, issue.2, p.382, 2017. ,
S146. Does the mean MEP amplitude scale with the phase of pericentral ?-rhythm? A state-informed open-loop EEG-TMS study, Clinical Neurophysiology, p.196, 2018. ,
, , 1996.
, Cortical excitability and response variability of transcranial magnetic stimulation, Journal of clinical neurophysiology, vol.13, issue.2, pp.164-171
The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse, Clinical neurophysiology, vol.115, issue.5, pp.1076-1082, 2004. ,
Inter-and intraindividual variability of paired-pulse curves with transcranial magnetic stimulation (TMS), Clinical neurophysiology, vol.113, issue.3, pp.376-382, 2002. ,
The variability of intracortical inhibition and facilitation, Clinical Neurophysiology, vol.114, issue.12, pp.2362-2369, 2003. ,
Major depressive disorder, Nature Reviews Disease Primers, vol.2, p.16065, 2016. ,